Price $72.02 |
Market Cap
19.93B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
27.0
|
P/B
3.78
|
P/S
4.94
|
Dividend %
-
|
|
P/CF
69.5
|
P/FCF
22.4
|
Op. Cash Flow
959K
|
FCF
3.6
|
|
Op. Margin
23.20%
|
Net Margin
18.60%
|
ROE
14.90%
|
ROI
17.50%
|
|
ROA
8.10%
|
EPS Growth
-50.60%
|
Current Ratio
4.1
|
Debt/Equity
58.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| LifeVantage Corp (LFVN) | $6.31 | - | 3.20% | 55.7M | Strong Buy |
| ProQR Therapeutics NV (PRQR) | $1.54 | - | - | 131.1M | Strong Buy |
| Psychemedics Corp. (PMD) | $3.78 | - | 6.10% | 26.1M | Strong Buy |
| Collegium Pharmaceutical Inc (COLL) | $22.55 | - | - | 743.4M | Strong Buy |
| Chromadex Corp (CDXC) | $1.42 | - | - | 117.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
